| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |